Cargando…

PD-1抑制剂Nivolumab对CD19嵌合抗原受体T细胞体外增殖和杀伤活性的影响

OBJECTIVE: To Evaluation the effect of PD-1 inhibitor Nivolumab on the proliferation and cytotoxicity of anti-CD19 chimeric antigen receptor T cells (CD19-CAR-T) in vitro. METHODS: Five patients with high PD-1 expression in peripheral blood and five healthy volunteers were selected. These peripheral...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342209/
https://www.ncbi.nlm.nih.gov/pubmed/30122019
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.07.011